Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals, Inc. (ICPT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intercept Pharmaceuticals, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1270073.
Total stock buying since 2014: $56,967,856.
Total stock sales since 2014: $941,992,580.
Total stock option exercises since 2014: $7,441,640.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 237,000 | $5,036,730 | 2,193 | $53,662 | 0 | $0 |
| 2020 | 0 | $0 | 6,291,496 | $370,845,750 | 0 | $0 |
| 2019 | 6,407 | $414,286 | 116,877 | $12,174,932 | 89,362 | $2,226,137 |
| 2018 | 798,045 | $51,074,880 | 1,569,444 | $164,779,277 | 57,425 | $613,786 |
| 2017 | 0 | $0 | 65,976 | $8,076,305 | 44,835 | $434,950 |
| 2016 | 0 | $0 | 56,747 | $8,693,631 | 61,626 | $600,726 |
| 2015 | 0 | $0 | 866,879 | $239,356,188 | 191,613 | $1,984,898 |
| 2014 | 2,800 | $441,960 | 477,468 | $138,012,835 | 163,199 | $1,581,143 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-11-25 | Bright Lisa (President International) | Sale | 249 | 113.60 | 28,286 |
| 2016-11-15 | Bright Lisa (President International) | Sale | 140 | 112.27 | 15,718 |
| 2016-10-31 | Mcminn Rachel (Chief Strategy Officer) | Sale | 129 | 123.82 | 15,972 |
| 2016-10-10 | Shapiro David (CMO and EVP - Development) | Sale | 411 | 153.34 | 63,022 |
| 2016-10-03 | Bright Lisa (See Remarks) | Sale | 155 | 163.20 | 25,296 |
| 2016-10-03 | Shapiro David (CMO and EVP - Development) | Sale | 1,513 | 163.13 | 246,815 |
| 2016-10-03 | Shapiro David (CMO and EVP - Development) | Option Ex | 1,350 | 21.50 | 29,025 |
| 2016-10-03 | Pruzanski Mark (CEO & President) | Sale | 705 | 163.20 | 115,055 |
| 2016-10-03 | Duncan Barbara Gayle (Chief Accounting Officer) | Sale | 147 | 163.20 | 23,990 |
| 2016-09-26 | Shapiro David (CMO and EVP - Development) | Sale | 3,545 | 165.40 | 586,325 |
| 2016-09-20 | Pruzanski Mark (CEO & President) | Sale | 35,000 | 165.00 | 5,775,000 |
| 2016-09-20 | Pruzanski Mark (CEO & President) | Option Ex | 35,000 | 9.24 | 323,575 |
| 2016-08-25 | Bright Lisa (President of International) | Sale | 246 | 159.00 | 39,114 |
| 2016-08-01 | Mcminn Rachel (Chief Strategy Officer) | Sale | 125 | 176.56 | 22,070 |
| 2016-07-15 | Pruzanski Mark (CEO & President) | Option Ex | 12,500 | 9.82 | 122,774 |
| 2016-07-05 | Bright Lisa (See Remarks) | Sale | 155 | 145.11 | 22,491 |
| 2016-07-05 | Mcminn Rachel (Chief Strategy Officer) | Sale | 106 | 145.11 | 15,381 |
| 2016-07-05 | Shapiro David (CMO and EVP - Development) | Sale | 163 | 145.11 | 23,652 |
| 2016-07-05 | Pruzanski Mark (CEO & President) | Sale | 714 | 145.11 | 103,607 |
| 2016-07-05 | Duncan Barbara Gayle (Chief Accounting Officer) | Sale | 146 | 145.11 | 21,185 |
| 2016-05-25 | Bright Lisa (See Remarks) | Sale | 251 | 137.50 | 34,511 |
| 2016-05-13 | Akkaraju Srinivas | Option Ex | 1,500 | 21.50 | 32,250 |
| 2016-05-02 | Mcminn Rachel (Chief Strategy Officer) | Sale | 130 | 147.49 | 19,173 |
| 2016-04-04 | Bright Lisa (See Remarks) | Sale | 153 | 130.76 | 20,006 |
| 2016-04-04 | Mcminn Rachel (Chief Strategy Officer) | Sale | 104 | 130.76 | 13,599 |
| 2016-04-04 | Shapiro David (CMO and EVP - Development) | Sale | 165 | 130.76 | 21,575 |
| 2016-04-04 | Pruzanski Mark (CEO & President) | Sale | 708 | 130.76 | 92,578 |
| 2016-04-04 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 144 | 130.76 | 18,829 |
| 2016-02-25 | Bright Lisa (See Remarks) | Sale | 241 | 115.22 | 27,768 |
| 2016-02-01 | Mcminn Rachel (Chief Strategy Officer) | Sale | 128 | 103.56 | 13,255 |
| 2016-01-13 | Bright Lisa (See Remarks) | Sale | 104 | 129.99 | 13,518 |
| 2016-01-12 | Bright Lisa (See Remarks) | Sale | 624 | 124.78 | 77,862 |
| 2016-01-04 | Mcminn Rachel (Chief Strategy Officer) | Sale | 469 | 145.90 | 68,428 |
| 2016-01-04 | Shapiro David (CMO and EVP - Development) | Sale | 533 | 145.90 | 77,766 |
| 2016-01-04 | Pruzanski Mark (CEO & President) | Sale | 2,126 | 145.90 | 310,191 |
| 2016-01-04 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 468 | 145.90 | 68,283 |
| 2016-01-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 1,623 | .00 | 0 |
| 2016-01-01 | Pruzanski Mark (CEO & President) | Option Ex | 4,868 | .00 | 0 |
| 2016-01-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 1,298 | .00 | 0 |
| 2015-12-18 | Shapiro David (CMO and EVP - Development) | Option Ex | 11,426 | 20.69 | 236,392 |
| 2015-12-15 | Shapiro David (CMO and EVP - Development) | Sale | 3,500 | 157.41 | 550,952 |
| 2015-12-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-11-25 | Bright Lisa (See Remarks) | Sale | 1,150 | 182.97 | 210,409 |
| 2015-11-20 | Williams Nicole | Sale | 973 | 167.00 | 162,491 |
| 2015-11-20 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-11-16 | Shapiro David (CMO and EVP - Development) | Sale | 4,264 | 178.75 | 762,177 |
| 2015-11-16 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-11-10 | Shapiro David (CMO and EVP - Development) | Sale | 3,500 | 204.15 | 714,525 |
| 2015-11-10 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-11-10 | Veitinger Klaus R Dr | Sale | 1,000 | 198.25 | 198,250 |
| 2015-11-10 | Veitinger Klaus R Dr | Option Ex | 1,000 | 21.50 | 21,500 |
| 2015-11-02 | Mcminn Rachel (Chief Strategy Officer) | Sale | 125 | 160.24 | 20,029 |
| 2015-10-28 | Akkaraju Srinivas | Option Ex | 1,250 | 21.50 | 26,875 |
| 2015-10-20 | Williams Nicole | Sale | 974 | 182.22 | 177,482 |
| 2015-10-20 | Williams Nicole | Option Ex | 974 | 9.82 | 9,566 |
| 2015-10-02 | Shapiro David (CMO and EVP - Development) | Sale | 858 | 159.04 | 136,455 |
| 2015-10-02 | Pruzanski Mark (CEO & President) | Sale | 167 | 159.04 | 26,559 |
| 2015-10-02 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 54 | 159.04 | 8,588 |
| 2015-10-01 | Shapiro David (CMO and EVP - Development) | Sale | 282 | 163.39 | 46,075 |
| 2015-10-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 1,622 | .00 | 0 |
| 2015-10-01 | Pruzanski Mark (CEO & President) | Option Ex | 4,867 | .00 | 0 |
| 2015-10-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2015-10-01 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 1,000 | 163.39 | 163,390 |
| 2015-10-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 2,298 | 4.33 | 9,957 |
| 2015-09-21 | Williams Nicole | Sale | 973 | 194.82 | 189,559 |
| 2015-09-21 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-09-15 | Shapiro David (CMO and EVP - Development) | Sale | 3,500 | 191.02 | 668,563 |
| 2015-09-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 8,794 | 8.67 | 76,217 |
| 2015-09-09 | Veitinger Klaus R Dr | Sale | 500 | 198.25 | 99,125 |
| 2015-09-09 | Veitinger Klaus R Dr | Option Ex | 500 | 21.50 | 10,750 |
| 2015-08-20 | Williams Nicole | Sale | 974 | 206.85 | 201,471 |
| 2015-08-20 | Williams Nicole | Option Ex | 974 | 9.82 | 9,566 |
| 2015-08-17 | Shapiro David (CMO and EVP - Development) | Sale | 4,272 | 209.37 | 894,428 |
| 2015-08-17 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-08-03 | Veitinger Klaus R Dr | Sale | 500 | 261.17 | 130,585 |
| 2015-08-03 | Veitinger Klaus R Dr | Option Ex | 500 | 21.50 | 10,750 |
| 2015-07-31 | Mcminn Rachel (Chief Strategy Officer) | Sale | 127 | 262.09 | 33,285 |
| 2015-07-24 | Fundaro Paolo | Sale | 582 | 285.00 | 165,870 |
| 2015-07-20 | Williams Nicole | Sale | 973 | 279.01 | 271,476 |
| 2015-07-20 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-07-10 | Pruzanski Mark (CEO & President) | Sale | 12,500 | 250.00 | 3,125,000 |
| 2015-07-10 | Pruzanski Mark (CEO & President) | Option Ex | 12,500 | 8.67 | 108,337 |
| 2015-07-06 | Adorini Luciano (Chief Scientific Officer) | Sale | 4,067 | 624.06 | 2,538,052 |
| 2015-07-06 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 4,067 | 15.08 | 61,342 |
| 2015-07-02 | Shapiro David (CMO and EVP - Development) | Sale | 851 | 237.76 | 202,336 |
| 2015-07-02 | Pruzanski Mark (CEO & President) | Sale | 158 | 237.76 | 37,566 |
| 2015-07-02 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 53 | 237.76 | 12,601 |
| 2015-07-01 | Shapiro David (CMO and EVP - Development) | Sale | 3,781 | 239.57 | 905,829 |
| 2015-07-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 5,123 | 4.33 | 30,334 |
| 2015-07-01 | Pruzanski Mark (CEO & President) | Option Ex | 4,868 | .00 | 0 |
| 2015-07-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2015-07-01 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 1,000 | 242.10 | 242,100 |
| 2015-07-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 2,298 | 4.33 | 8,667 |
| 2015-06-22 | Williams Nicole | Sale | 974 | 265.14 | 258,246 |
| 2015-06-22 | Williams Nicole | Option Ex | 974 | 9.82 | 9,566 |
| 2015-06-15 | Shapiro David (CMO and EVP - Development) | Sale | 3,500 | 241.54 | 845,393 |
| 2015-06-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-06-10 | Veitinger Klaus R Dr | Sale | 391 | 238.21 | 93,140 |
| 2015-06-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2015-06-08 | Adorini Luciano (Chief Scientific Officer) | Sale | 4,000 | 248.40 | 993,600 |
| 2015-06-08 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 4,000 | 8.67 | 34,668 |
| 2015-06-03 | Pruzanski Mark (CEO & President) | Option Ex | 6,561 | 15.08 | 98,959 |
| 2015-05-20 | Williams Nicole | Sale | 973 | 260.20 | 253,174 |
| 2015-05-20 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-05-19 | Akkaraju Srinivas | Option Ex | 1,000 | 21.50 | 21,500 |
| 2015-05-15 | Shapiro David (CMO and EVP - Development) | Sale | 4,279 | 306.95 | 1,313,447 |
| 2015-05-15 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 8.67 | 30,334 |
| 2015-05-14 | Pruzanski Mark (CEO & President) | Sale | 5,000 | 300.00 | 1,500,000 |
| 2015-05-14 | Pruzanski Mark (CEO & President) | Option Ex | 5,000 | 8.67 | 43,335 |
| 2015-05-11 | Veitinger Klaus R Dr | Sale | 391 | 278.06 | 108,721 |
| 2015-05-11 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2015-05-06 | Adorini Luciano (Chief Scientific Officer) | Sale | 4,000 | 260.54 | 1,042,167 |
| 2015-05-06 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 4,000 | 8.67 | 34,668 |
| 2015-05-01 | Mcminn Rachel (Chief Strategy Officer) | Sale | 503 | 255.12 | 128,327 |
| 2015-05-01 | Pruzanski Mark (CEO & President) | Sale | 12,500 | 255.23 | 3,190,350 |
| 2015-05-01 | Pruzanski Mark (CEO & President) | Option Ex | 12,500 | 8.67 | 108,337 |
| 2015-04-20 | Williams Nicole | Sale | 974 | 278.50 | 271,259 |
| 2015-04-20 | Williams Nicole | Option Ex | 974 | 9.82 | 9,566 |
| 2015-04-10 | Veitinger Klaus R Dr | Sale | 391 | 272.10 | 106,391 |
| 2015-04-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2015-04-06 | Adorini Luciano (Chief Scientific Officer) | Sale | 4,000 | 268.98 | 1,075,908 |
| 2015-04-06 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 4,000 | 8.67 | 34,668 |
| 2015-04-02 | Shapiro David (CMO and EVP - Development) | Sale | 843 | 277.70 | 234,101 |
| 2015-04-02 | Pruzanski Mark (CEO & President) | Sale | 157 | 277.70 | 43,599 |
| 2015-04-02 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 39 | 277.70 | 10,830 |
| 2015-04-01 | Shapiro David (CMO and EVP - Development) | Sale | 2,616 | 274.56 | 718,235 |
| 2015-04-01 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,956 | 6.36 | 25,144 |
| 2015-04-01 | Pruzanski Mark (CEO & President) | Option Ex | 4,868 | .00 | 0 |
| 2015-04-01 | Adorini Luciano (Chief Scientific Officer) | Option Ex | 649 | .00 | 0 |
| 2015-04-01 | Duncan Barbara Gayle (Chief Financial Officer) | Option Ex | 1,298 | .00 | 0 |
| 2015-03-27 | Duncan Barbara Gayle (Chief Financial Officer) | Sale | 1,000 | 288.94 | 288,937 |
| 2015-03-26 | Silverstein Jonathan | Sale | 157,200 | 287.71 | 45,228,797 |
| 2015-03-26 | Isaly Samuel D | Sale | 157,200 | 287.71 | 45,228,797 |
| 2015-03-25 | Silverstein Jonathan | Sale | 2,800 | 270.23 | 756,644 |
| 2015-03-25 | Isaly Samuel D | Sale | 2,800 | 270.23 | 756,644 |
| 2015-03-24 | Silverstein Jonathan | Sale | 45,600 | 271.80 | 12,394,034 |
| 2015-03-24 | Isaly Samuel D | Sale | 45,600 | 271.80 | 12,394,034 |
| 2015-03-23 | Silverstein Jonathan | Sale | 159,400 | 278.64 | 44,415,056 |
| 2015-03-23 | Isaly Samuel D | Sale | 159,400 | 278.64 | 44,415,056 |
| 2015-03-20 | Williams Nicole | Sale | 973 | 305.36 | 297,115 |
| 2015-03-20 | Williams Nicole | Option Ex | 973 | 9.82 | 9,556 |
| 2015-03-16 | Shapiro David (CMO and EVP - Development) | Sale | 3,500 | 285.88 | 1,000,573 |
| 2015-03-16 | Shapiro David (CMO and EVP - Development) | Option Ex | 3,500 | 10.40 | 36,400 |
| 2015-03-12 | Shapiro David (CMO and EVP - Development) | Sale | 5,000 | 285.99 | 1,429,940 |
| 2015-03-12 | Shapiro David (CMO and EVP - Development) | Option Ex | 5,000 | 8.67 | 43,335 |
| 2015-03-10 | Veitinger Klaus R Dr | Sale | 391 | 262.25 | 102,539 |
| 2015-03-10 | Veitinger Klaus R Dr | Option Ex | 391 | 21.50 | 8,406 |
| 2015-02-24 | Veitinger Klaus R Dr | Sale | 632 | 222.50 | 140,620 |
| 2015-02-24 | Veitinger Klaus R Dr | Option Ex | 632 | 21.50 | 13,588 |
| 2015-02-20 | Williams Nicole | Sale | 974 | 216.00 | 210,384 |
Insider trading activities including stock purchases, stock sales, and option exercises of ICPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intercept Pharmaceuticals, Inc. (symbol ICPT, CIK number 1270073) see the Securities and Exchange Commission (SEC) website.